Overview


According to FutureWise analysis, the market for Newborn Calf Serum is expected to grow with a CAGR of 6.8% over the forecast period 2023-2031, and reach a market value of US$ 0.39 Billion by 2031. 

Newborn Calf Serum (NCS) holds a significant position in cell culture technology, particularly in biopharmaceutical, biotechnology, and veterinary research. It is a nutrient-rich, serum-derived component extracted from the blood of newborn calves shortly after birth. This serum is abundant in essential growth factors, hormones, and nutrients vital for supporting the growth and proliferation of cells in culture.

NCS plays a critical role in providing the necessary environment for cell culture. It serves as a reservoir of essential proteins, lipids, vitamins, and minerals that facilitate cellular metabolism and cell replication for various applications. It becomes a necessary additive for nurturing diverse cell lines in a controlled laboratory environment, encompassing those employed in vaccine manufacturing, antibody formulation, and stem cell investigations. One of the paramount attributes of NCS is its ability to support the expansion of various cell types, including those derived from humans and animals. This versatility has led to its widespread utilization in research and industrial settings. In biopharmaceutical production, NCS is employed in manufacturing vaccines and biologics, where its nutrient-rich composition aids in the propagation of cells required for these critical medical products. Within the realm of biotechnology, NCS plays a crucial role as a fundamental element in generating recombinant proteins and monoclonal antibodies and advancing the field of gene therapies.

FutureWise Market Research has published a report that provides an insightful analysis of Newborn Calf Serum Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the Newborn Calf Serum Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • HiMedia Laboratories
  • Thermo Fisher Scientific Inc.
  • Sartorius AG 
  • Merck KGaA
  • Corning Inc.
  • Atlas Biologicals, Inc.
  • TCS Biosciences Ltd. 
  • Bovogen Biologicals Pty Ltd.
  • Novus Biologicals, LLC
  • Capricorn Scientific
  • PAN-Biotech GmbH 
  • Atlanta Biologicals, Inc.
  • Rockey Mountain Biologicals
  • GE Healthcare 
  • Serana
  • Zhejiang Tianhang Biotechnology.

(Note: The list of the major players will be updated with the latest market scenario and trends)

The expanding biopharmaceutical and biotechnology sectors, which heavily rely on cell culture techniques, are driving the demand for newborn calf serum (NCS) as a vital component in cell culture media. The increasing global demand for vaccines and biologics necessitates using high-quality NCS in production, as it serves as a nutrient-rich medium for cell growth, hence driving the market.  NCS is a critical component in veterinary diagnostics and research applications, where it provides essential nutrients and growth factors for cell culture studies involving animals.  The surge in stem cell research in academia and the biopharmaceutical industry bolstered the demand for NCS, an essential component for developing and maintaining specific stem cell lines. End-users, particularly in industries related to biopharmaceuticals and biotechnology, prioritize the use of high-quality, ethically sourced NCS, which aligns with concerns for animal welfare and the assurance of product quality, propelling the market.

However, using animal-derived products, including NCS, raises ethical considerations regarding animal welfare and environmental impact. This can influence consumer preferences and purchasing decisions. Ensuring the safety and quality of NCS is paramount, especially with concerns about potential contaminants, such as viruses or prions, that could affect the cells being cultured and hence hinder the market growth.

By Origin

  • New Zealand Origin
  • S. Origin
  • Australia Origin
  • Others (Brazil Origin, Mexico Origin, etc.)

By Application

  • Drug Discovery
  • Cell Media Culture
  • Others

By End User

  • Biotechnology & Pharmaceutical Industries
  • Academic Institutes
  • Others (Research labs and Diagnostic Labs, etc.)

By Region

  • Europe
  • North America
  • Asia Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market, which is based on the conclusion of primary interviews and secondary data points gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022 owing to an increase in vaccine production, robust healthcare infrastructure, the prominent presence of key industry players, a surge in chronic disease cases, and heightened research endeavors in this geographical region. 

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Newborn Calf Serum Market By Origin, By Application, By End User, and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction
    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology
    •   1 Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3.Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Newborn Calf Serum Market Variables, Trends & Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview
    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Newborn Calf Serum Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Newborn Calf Serum Market Analysis Tools
    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Newborn Calf Serum Market, By Origin Historical Analysis and Forecast 2023-2031 (USD Million)
      1. New Zealand Origin
      2. S. Origin
      3. Australia Origin
      4. Others (Brazil Origin, Mexico Origin, etc.)
         
  • 8.  Newborn Calf Serum Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
      1. Drug Discovery
      2. Cell Media Culture
      3. Others
         
  • 9.  Newborn Calf Serum Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
      1. Biotechnology & Pharmaceutical Industries
      2. Academic Institutes
      3. Others (Research labs and Diagnostic Labs, etc.)
         
  • 10.  North America Newborn Calf Serum Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.  Latin America Newborn Calf Serum Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.  Europe Newborn Calf Serum Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.  Asia Pacific Newborn Calf Serum Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.  Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.  Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 16.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
    •   1. HiMedia Laboratories
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. SWOT Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. Thermo Fisher Scientific Inc.
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. SWOT Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. Sartorius AG
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. SWOT Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. Merck KGaA
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. SWOT Analysis
           4.4. Financial Overview
           4.5. Strategic Overview
        5. Corning Inc.
           5.1. Company Overview
           5.2. Product Portfolio
           5.3. SWOT Analysis
           5.4. Financial Overview
           5.5. Strategic Overview
        6. Atlas Biologicals, Inc.
           6.1. Company Overview
           6.2. Product Portfolio
           6.3. SWOT Analysis
           6.4. Financial Overview
           6.5. Strategic Overview
        7. TCS Biosciences Ltd.
           7.1. Company Overview
           7.2. Product Portfolio
           7.3. SWOT Analysis
           7.4. Financial Overview
           7.5. Strategic Overview
        8. Bovogen Biologicals Pty Ltd.
           8.1. Company Overview
           8.2. Product Portfolio
           8.3. SWOT Analysis
           8.4. Financial Overview
           8.5. Strategic Overview
        9. Novus Biologicals, LLC
           9.1. Company Overview
           9.2. Product Portfolio
           9.3. SWOT Analysis
           9.4. Financial Overview
           9.5. Strategic Overview
        10. Capricorn Scientific
           10.1. Company Overview
           10.2. Product Portfolio
           10.3. SWOT Analysis
           10.4. Financial Overview
           10.5. Strategic Overview
        11. PAN-Biotech GmbH
           11.1. Company Overview
           11.2. Product Portfolio
           11.3. SWOT Analysis
           11.4. Financial Overview
           11.5. Strategic Overview
        12. Atlanta Biologicals, Inc.
           12.1. Company Overview
           12.2. Product Portfolio
           12.3. SWOT Analysis
           12.4. Financial Overview
           12.5. Strategic Overview
        13. Rockey Mountain Biologicals
           13.1. Company Overview
           13.2. Product Portfolio
           13.3. SWOT Analysis
           13.4. Financial Overview
           13.5. Strategic Overview
        14. GE Healthcare
           14.1. Company Overview
           14.2. Product Portfolio
           14.3. SWOT Analysis
           14.4. Financial Overview
           14.5. Strategic Overview
        15. Serana
           15.1. Company Overview
           15.2. Product Portfolio
           15.3. SWOT Analysis
           15.4. Financial Overview
           15.5. Strategic Overview
        16. Zhejiang Tianhang Biotechnology
           16.1. Company Overview
           16.2. Product Portfolio
           16.3. SWOT Analysis
           16.4. Financial Overview
           16.5. Strategic Overview

  • 17.  Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
            administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.  FutureWise SME Key Takeaway Points for Client
    •   

Partner

Our Clients